Respiratory syncytial virus vaccine (Sanofi Pasteur)

呼吸道合胞病毒减毒活疫苗(赛诺菲巴斯德)

Report date: 2026/02/04 20:00:52

Base Information

Drug NameRespiratory syncytial virus vaccine (Sanofi Pasteur)
Drug Alias NameRSVt Vaccine (Sanofi Pasteur)SP0125SP-0125534
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccine +[4
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesThailandPuerto Rico +[18
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A